Cala Health has collaborated with the University of California, San Francisco (UCSF), US, to develop tailored peripheral nerve stimulation treatments based on the former鈥檚 neuromodulation and data science platform technology.
A bioelectronic medicine company, Cala Health combines innovations in neuroscience and technology to create wearable therapies for chronic diseases.
As part of the alliance, the company will collaborate with UCSF Weill Institute of Neuroscience neurology associate professor and neural engineering expert Dr Karunesh Ganguly, as well as others, to develop non-invasive therapies for critical neurological diseases.
Cala Health founder and chief scientific officer Kate Rosenbluth said: 鈥淒r Ganguly鈥檚 pioneering research on the precise targeting of electrical stimulation to modulate neural networks provides an exciting path to personalise therapy to each patient.
鈥淭his partnership takes Cala Health one step closer to reaching our goal to give the millions of patients suffering from debilitating neurological disorders access to non-invasive, efficacious therapies that improve their quality of life.鈥�
The technologies licenced from UCSF under this collaboration will aid Cala Health to grow its pipeline of neurology treatments.
US Tariffs are shifting - will you react or anticipate?
Don鈥檛 let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataFurthermore, the collaboration will boost the company鈥檚 mechanistic research to create new tailored treatments as well as aiding in incorporating its data science platform to develop software-enabled customised treatment insights for patients in a timely manner.
Ganguly said: 鈥淚n my clinical work, I see the profound impacts of motor impairments from a wide range of neurological conditions such as brain injury and Parkinson鈥檚 disease, and we are committed to advancing new treatments to enhance motor function.
鈥淭he UCSF team looks forward to a fruitful partnership with Cala to advance peripheral nerve stimulation as a treatment to improve motor function.鈥�
Recently, Cala Health introduced its transcutaneous afferent patterned stimulation therapy, Cala Trio, for treating hand tremors in the movement disorder essential tremor.
